Quantitative evaluation of DNA hypermethylation in malignant and benign breast tissue and fluids. (1/14)

Nipple aspirate fluid and ductoscopy to detect breast cancer. (2/14)

Nipple discharge screening. (3/14)

Sulindac and sulindac metabolites in nipple aspirate fluid and effect on drug targets in a phase I trial. (4/14)

Gene methylation in breast ductal fluid from BRCA1 and BRCA2 mutation carriers. (5/14)

Patterns of sex steroid hormones in nipple aspirate fluid during the menstrual cycle and after menopause in relation to serum concentrations. (6/14)

Nipple aspirate fluid proteome of healthy females and patients with breast cancer. (7/14)

Successful oxytocin-assisted nipple aspiration in women at increased risk for breast cancer. (8/14)

• 1
• 2